InvaGen Pharmaceuticals, Inc. → AVENUE THERAPEUTICS, INC. ATXI

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

1 shares short · 0.0% vs prior

Other 13D/G Filings on AVENUE THERAPEUTICS, INC.

Filed	Form	Filer	Stake	Shares
2026-01-06	SCHEDULE	Fortress Biotech, Inc.	13.40%	439,955	view →
2025-04-02	SCHEDULE	Fortress Biotech, Inc.	10.30%	328,746	view →
2025-01-03	SCHEDULE	Fortress Biotech, Inc.	13.80%	295,022	view →
2024-01-02	SC	SABBY MANAGEMENT, LLC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →